Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 18;25(2):63.
doi: 10.31083/j.rcm2502063. eCollection 2024 Feb.

Is CRT Optimization Obsolete? A Referral Center's Experience

Affiliations

Is CRT Optimization Obsolete? A Referral Center's Experience

Shmaila Saleem-Talib et al. Rev Cardiovasc Med. .

Abstract

Background: Cardiac resynchronization therapy (CRT) is a well-established therapy for patients with heart failure (HF). However, 30% of HF patients do not show any improvement in clinical status after CRT implantation. In this study, we report our echocardiography-based CRT optimization methodology, in daily practice at our CRT referral center.

Methods: We included 350 ambulatory patients, who were referred to our center for optimization after CRT implantation. A protocol-driven echocardiographic approach for adjusting mechanical dyssynchrony, whereby adjusting for ventriculoventricular (VV) delays with strain and atrioventricular (AV) delays with Doppler echocardiography was performed. We defined changes in left ventricular ejection fraction (LVEF) and New York Heart Association (NYHA) classes as outcome variables in the evaluation of the CRT outcomes.

Results: Optimization was obtained in 288 (82%) patients. VV and AV timings were adjusted to 61% and 51%, respectively. In 3%, biventricular pacing was turned off and in 3% left ventricular (LV) only pacing was programmed. The LVEF and NYHA class showed significant improvements in all patients who underwent CRT optimization.

Conclusions: CRT optimization remains valuable in improving LVEF and functional status measured using the NYHA class in all patients receiving CRT devices.

Keywords: CRT-optimization; cardiac resynchronization therapy; strain rate imaging.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
Measuring left ventricular (LV) dyssynchrony with peak longitudinal strain derived from strain rate imaging (SRI). The method used to measure dyssynchrony with SRI. Peak longitudinal strain curves from the mid-septum (left panel) and mid-lateral wall (right panel) in a patient undergoing mechanical delay pre-cardiac resynchronization therapy (CRT) optimization of 260 ms – 90 ms = 170 ms, measured from the opening of the aortic valve to the maximal strain of the mid-septum and mid-lateral wall in the left ventricle. Mechanical dyssynchrony is exhibited. Post-CRT optimization of the mechanical delay between the mid-septum and the mid-lateral walls was reduced to 260 ms – 250 ms = 10 ms. AVC, aortic valve closed; AVO, aortic valve open; MVC, mitral valve closed; MVO, mitral valve open.
Fig. 2.
Fig. 2.
CRT modulation. Abbreviations: N, number (n = 350); VV, VV interval programming; AV, AV interval modification; allP, VV, and AV combined; NoC, no changes were necessary; LV, LV only pacing; AF, VV interval adaptation in patients with atrial fibrillation; Off, pacing mode switched off; noOpt, no changes could be made. Suboptimal VV intervals were adjusted in 215 patients, while the AV settings were modified in 178 patients according to the iterative method. Both VV and AV interval (allP) optimizations were performed in 141 patients, while no changes were necessary (NoC) in 62 patients. Device settings were already optimal at baseline. CRT was programmed in 9 patients to LV only. In 29 patients, VV programming only could be performed due to underlying atrial fibrillation (AF). The CRT was turned off in 10 patients because they did not have dyssynchrony (Off) at baseline. Furthermore, optimization failed (noOpt) in 15 patients due to arrhythmias. VV, ventriculoventricular; AV, atrioventricular; LV, left ventricle; CRT, cardiac resynchronization therapy.
Fig. 3.
Fig. 3.
LVEF improvement after CRT optimization. Abbreviations: LVEF, left ventricular ejection fraction; CRT, cardiac resynchronization therapy; Pre, before CRT implantation; Post, after CRT implantation but before CRT optimization; Opt, after CRT optimization. The median LVEF prior to CRT implantation was 30%. After implantation, there was a significant improvement in median LVEF to 35%. After CRT optimization, the median LVEF further improved to 39% (p < 0.04). There were 344 patients with LVEF measurements available.
Fig. 4.
Fig. 4.
LVEF improvement after CRT optimization in responders and non-responders. Abbreviation: N, number; R LVEF, responders left ventricular ejection fraction; NR LVEF, non-responders left ventricular ejection fraction; NR after Opt, number of non-responders after optimization; All, all non-responders; >, increase in LVEF; =, no difference in LVEF; <, decrease in LVEF; Post, post CRT implantation but before CRT optimization; Opt, after CRT optimization; CRT, cardiac resynchronization therapy. Based on the selection criteria for R and NR, there were 184 R and 160 NR at baseline. LVEF showed significant improvements before and after optimization in both the R and NR groups.
Fig. 5.
Fig. 5.
Improvements in NYHA class after CRT optimization. Abbreviations: Pre, before CRT implantation; Post, after CRT implantation but before CRT optimization; Opt, after CRT optimization; NYHA, New York Heart Association classification; CRT, cardiac resynchronization therapy. After CRT implantation, the NYHA class improved in all 350 patients, while the NYHA class further improved after optimization, with a greater number of patients exhibiting NYHA class I (104 patients). After optimization, 198 patients were in NYHA class II. The number of patients in NYHA classes III and IV were reduced to 46 and 2 patients, respectively, meaning the optimization resulted in a significant improvement p < 0.01.

References

    1. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Cardiac resynchronization in chronic heart failure. The New England Journal of Medicine . 2002;346:1845–1853. - PubMed
    1. Cleland JGF, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. The New England Journal of Medicine . 2005;352:1539–1549. - PubMed
    1. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. The New England Journal of Medicine . 2009;361:1329–1338. - PubMed
    1. Mullens W, Auricchio A, Martens P, Witte K, Cowie MR, Delgado V, et al. Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care: A joint position statement from the Heart Failure Association (HFA), European Heart Rhythm Association (EHRA), and European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology. European Journal of Heart Failure . 2020;22:2349–2369. - PubMed
    1. Mullens W, Auricchio A, Martens P, Witte K, Cowie MR, Delgado V, et al. Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care. Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology . 2021;23:1324–1342. - PubMed

LinkOut - more resources